Brentuximab for Newly Diagnosed Hodgkin Disease

Clinical trial NCT02398240 · COMPLETED

Trial details

NCT number: NCT02398240
Sponsor: Mitchell Cairo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2015-05-01
Primary completion: 2022-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.